Clifton R. LaDuane's Form 4 filing
Zevra Therapeutics, Inc.ZVRA · filed Oct 3, 2022
- Accession no.
- 0001437749-22-023512
- Filed
- Oct 3, 2022
- Trade date
- Sep 30, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $5.98K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Clifton R. LaDuaneCIK 0001488774 | Officer (CFO, Secretary & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2022 | Common Stock | PPurchaseAcquired | +600 | $5.98 | +$3,588 | 7,709 | Direct | |
| Sep 30, 2022 | Common Stock | PPurchaseAcquired | +400 | $5.98 | +$2,392 | 8,109 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.